Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’ - McKesson (NYSE:MC
Jim Cramer called McKesson (NYSE:MCK) a 'winner' and expects it to rise further. Leerink Partners raised its price target to $1,070. Cramer criticized X-Energy (NASDAQ:XE) for losing money, while Morgan Stanley lowered its target to $34. He advised waiting for Vishay Precision (NYSE:VPG) to drop 10% before buying. Medtronic (NYSE:MDT) was favored over MiniMed (NASDAQ:MMED), with BTIG lowering its target to $99. Cramer also discouraged investing in Cipher (NASDAQ:CIFR) due to losses.
How this was made
The 30-second read
Why it matters
The segment generated modest price moves but no substantive new corporate events.
Market read
The commentary sparked short‑term moves in the mentioned stocks but offers limited actionable insight.
What to watch
Upcoming earnings releases and broader market sentiment could dominate price action more than today’s commentary.
Background
Jim Cramer provided a rapid‑fire set of opinions on several health‑care stocks during a CNBC segment, accompanied by recent analyst rating changes.
Ticker impact
Jim Cramer called McKesson a “winner” and said it will go much higher, citing an analyst upgrade.
likely upward pressure as traders price in the bullish commentary
Cramer endorsement and price target increase are fresh but not a material catalyst.
Cramer said X‑Energy is losing too much money; Morgan Stanley lowered its price target.
likely pressure as investors react to the criticism and lower target
The remarks are new but the company already faced a price decline.
Cramer noted Vishay Precision Group is valued too high and advised waiting for a dip.
possible short‑term weakness if investors heed the warning
Commentary only, no concrete catalyst.
Cramer said he would buy Medtronic instead of MiniMed Group.
potential modest upside as traders note the recommendation
Endorsement is new but limited in scope.
Cramer warned that Cipher is losing a ton of money and should go down; the company announced a convertible notes offering.
likely downward pressure as investors react to the criticism and financing news
Both commentary and financing news are fresh, but impact is modest.
Market effects
Healthcare and medical device sector receives mixed signals from analyst commentary.
U.S. equities may see slight volatility in health‑care stocks.
Limited to U.S. listed health‑care companies.
Counterpoint
Some investors may view the bullish comments as overhyped and wait for clearer fundamentals.
Key entities
- personJim Cramer
Host of CNBC's Mad Money Lightning Round
- firmLeerink Partners
Analyst firm that raised MCK price target
- firmMorgan Stanley
Analyst firm that cut XE price target
